Latest filing published 04 Jun 2026 for Ceribell, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Erica J. Rogers: trading record in brief
Erica J. Rogers is a declared insider at 3 companies (chief executive); the most frequent names are Silk Road Medical Inc, Sight Sciences, Inc. and Ceribell, Inc. We count 124 filings; the first trade dates from 8 April 2019 and the latest from 2 June 2026.
Both buying and selling appear: 1 purchase worth €91k, against 53 sales worth €23.7M. Taken together, the sales exceed the purchases by €23.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 18 share grants and 50 option exercises.
The record was last updated on 4 June 2026 with a share grant in Ceribell, Inc. The last insider purchase was made public on 30 November 2021, 1,805 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Erica J. Rogers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,838 shares0Common StockSEC:0001193125-26-257731:0
- 25,216 shares0Common StockSEC:0001193125-25-209534:0
- 30,952 shares0Common StockSEC:0000950170-25-084072:0
- 17,366 shares0Common StockSEC:0000950170-24-071515:0
- 1,651 shares@ US$56.618910.6% of flowCommon StockSEC:0001593968-23-001343:0
- 1,000 shares@ US$31.560.1% of flowCommon StockSEC:0001593968-23-001120:1
- 1,000 shares@ US$1.600.3% of flowCommon StockSEC:0001593968-23-001120:0
- 1,000 shares@ US$1.600.0% of flowCommon StockSEC:0001593968-23-000992:1
- 1,000 shares@ US$32.130.1% of flowCommon StockSEC:0001593968-23-000992:2
- 507 shares@ US$26.172.8% of flowCommon StockSEC:0001593968-23-000992:0
- 15,094 shares0Common StockSEC:0000899243-23-015392:1
- 11,940 shares0Common StockSEC:0000899243-23-015392:0
- 2,000 shares@ US$1.600.0% of flowCommon StockSEC:0001593968-23-000796:1
- 1,000 shares@ US$35.510.1% of flowCommon StockSEC:0001593968-23-000796:2
- 2,000 shares@ US$35.510.3% of flowCommon StockSEC:0001593968-23-000796:3
- 1,000 shares@ US$1.600.3% of flowCommon StockSEC:0001593968-23-000796:0
- 6,000 shares@ US$39.770.9% of flowCommon StockSEC:0001593968-23-000601:1
- 6,000 shares@ US$1.602.0% of flowCommon StockSEC:0001593968-23-000601:0
- 6,000 shares@ US$42.231.0% of flowCommon StockSEC:0001593968-23-000485:1
- 6,000 shares@ US$1.602.1% of flowCommon StockSEC:0001593968-23-000485:0
- 18,043 shares@ US$47.103.2% of flowCommon StockSEC:0001593968-23-000426:1
- 40,976 shares0Common StockSEC:0001593968-23-000426:0
- 6,000 shares@ US$50.941.2% of flowCommon StockSEC:0001593968-23-000323:1
- 6,000 shares@ US$1.602.1% of flowCommon StockSEC:0001593968-23-000323:0
- 6,000 shares@ US$51.531.2% of flowCommon StockSEC:0001593968-23-000140:1
25 of 124 declarations